Axon Enterprise, Inc.
Case Overview
| Status: | Status:Investigating |
| Company Name: | Company Name:Axon Enterprise, Inc. |
| Ticker: | Ticker:AXON |
| Related Attorneys: | Lead Attorneys:Thomas W. Elrod |
| Related Practices: | Related Practices:Securities |
On November 5, 2026, Axon announced its third quarter 2026 financial results, reporting quarterly revenue of approximately $909 million, $25 million to $29 million below analyst consensus estimates of $934 million to $938 million, as well as earnings of $1.72 per share, short of the $1.88 to $1.91 analysts expected. The Company also disclosed that 3 Federal Dedrone deployments, representing $130 million of revenue and $200 million of bookings, would be delayed into 2027. Specifically, Axon announced that a $30 million Federal Dedrone deployment would be “moved out of Q3,” and that “our Q4 outlook no longer assumed 2 large Federal Dedrone deployments totaling approximately $100 million.” Axon President Joshua Isner stated, “We’re seeing some delays, and we can’t be sure those come through this year.” On this news, the price of Axon shares declined by $69.56 per share, or approximately 18.18%, from $382.56 per share on November 5, 2026 to close at $313.00 on November 6, 2026.